United Kingdom · Question · Written question
UIN 35722
Sacituzumab Govitecan
Original
Introduced
19 July 2021
Last action
27 July 2021 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
27 July 2021
Summary
To ask the Secretary of State for Health and Social Care, when the cancer treatment drug Sacituzumab Govitecan, also known as Trodelvy, will be available for prescription and use in the NHS.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
19 July 2021
Written question
To ask the Secretary of State for Health and Social Care, when the cancer treatment drug Sacituzumab Govitecan, also known as Trodelvy, will be available for prescription and use in the NHS.
Source: Commons
27 July 2021
Answer
Trodelvy (sacituzumab govitecan) does not yet have a marketing authorisation for use in Great Britain and is not yet available for routine prescribing. The Medicines and Healthcare products Regulatory Agency is currently considering a marketing authorisat...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2021-07-19/35722
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1348066
- uk · wq-1348066 · source updated 27 July 2021